gms | German Medical Science

61. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC) im Rahmen der Neurowoche 2010
Joint Meeting mit der Brasilianischen Gesellschaft für Neurochirurgie am 20. September 2010

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

21. - 25.09.2010, Mannheim

Donor age dependent graft development and recovery in a rat model of Huntington's disease: Cellular and behavioural analysis

Meeting Abstract

  • Steffi Schackel - Laboratory of Molecular Neurosurgery, Deptartment of Stereotactic Neurosurgery, University Hospital Freiburg-Neurocentre, Freiburg, Germany
  • Anita Papazoglou - Laboratory of Molecular Neurosurgery, Deptartment of Stereotactic Neurosurgery, University Hospital Freiburg-Neurocentre, Freiburg, Germany
  • Robert Kirch - Laboratory of Molecular Neurosurgery, Deptartment of Stereotactic Neurosurgery, University Hospital Freiburg-Neurocentre, Freiburg, Germany
  • Guido Nikkhah - Laboratory of Molecular Neurosurgery, Deptartment of Stereotactic Neurosurgery, University Hospital Freiburg-Neurocentre, Freiburg, Germany
  • Máté Döbrössy - Laboratory of Molecular Neurosurgery, Deptartment of Stereotactic Neurosurgery, University Hospital Freiburg-Neurocentre, Freiburg, Germany

Deutsche Gesellschaft für Neurochirurgie. 61. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC) im Rahmen der Neurowoche 2010. Mannheim, 21.-25.09.2010. Düsseldorf: German Medical Science GMS Publishing House; 2010. DocP1890

DOI: 10.3205/10dgnc361, URN: urn:nbn:de:0183-10dgnc3613

Veröffentlicht: 16. September 2010

© 2010 Schackel et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective: Clinical trials of fetal striatal grafts in HD patients have so far shown a range of outcomes from no effect to disease modifying capability. Amongst the many variables involved is the age of the donor embryo at the time of grafting. In this study we aim to shed more light on how embryonic striatal cells from different aged donors develop in vivo, what kind of cell populations they contain, how and for how long grafted cells proliferate, how they reconnect with the host, and how they influence behavioural recovery.

Methods: 50 rats were used for the study of which 40 were lesioned unilaterally with QA (0.12M). 14 days later, animals received single cell suspension grafts equivalent of one whole ganglionic eminence (WGE) from E13 (n=10), E14 (n=10), E15 (n=10) donors, or remained lesioned only. Half of the animals in each grafted group were injected 3 times with BrdU (50 mg/kg) following the next 48 hours to visualize cellular proliferation, and the other half received BrdU injections according to the same schedule 21 days post-grafting. All animals were tested on the Cylinder test, the Corridor test, and on drug-induced rotation at baseline, post-lesion/ pre-grafting, and at 6 and 10 weeks post-grafting. A week prior to perfusion, a sub-group in each grafted group received fluorogold injections into the ipsilateral globus pallidus to study graft re-innervation. Animals were perfused 10 weeks post-grafting and submitted to staining and image analysis.

Results: The extent of functional recovery was shown to be dependent on i.) age of the embryonic donor tissue; ii.) context of the behavioural test; and iii.) delay between the grafting and the testing. E13 tissue grafts gave the best overall outcome.

Conclusions: The behavioural and histological data suggests that tissue from different donor age have different potential to promote functional recovery.